Migraine Prevention: Botox Wins, but Another Drug Enters the Ring Migraine Prevention: Botox Wins, but Another Drug Enters the Ring

An open-label study prefers Botox over topiramate, but a new migraine prophylactic drug has joined the market, raising options as well as questions.Medscape Internal Medicine

Source: Medscape Today Headlines - July 30, 2018 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news